277 related articles for article (PubMed ID: 33687521)
1. Plasma cell myeloma: role of histopathology, immunophenotyping, and genetic testing.
Fitzpatrick MJ; Nardi V; Sohani AR
Skeletal Radiol; 2022 Jan; 51(1):17-30. PubMed ID: 33687521
[TBL] [Abstract][Full Text] [Related]
2. Genetic abnormalities and patterns of antigenic expression in multiple myeloma.
Mateo G; Castellanos M; Rasillo A; Gutiérrez NC; Montalbán MA; Martín ML; Hernández JM; López-Berges MC; Montejano L; Bladé J; Mateos MV; Sureda A; de la Rubia J; Díaz-Mediavilla J; Pandiella A; Lahuerta JJ; Orfao A; San Miguel JF
Clin Cancer Res; 2005 May; 11(10):3661-7. PubMed ID: 15897562
[TBL] [Abstract][Full Text] [Related]
3.
Hui H; Fuller KA; Eresta Jaya L; Konishi Y; Ng TF; Frodsham R; Speight G; Yamada K; Clarke SE; Erber WN
J Clin Pathol; 2023 Nov; 76(11):763-769. PubMed ID: 36113967
[TBL] [Abstract][Full Text] [Related]
4. Recurrent Cytogenetic Abnormalities in Multiple Myeloma.
Chan NC; Chan NP
Methods Mol Biol; 2017; 1541():295-302. PubMed ID: 27910031
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells.
Schmidt-Hieber M; Gutiérrez ML; Pérez-Andrés M; Paiva B; Rasillo A; Tabernero MD; Sayagués JM; Lopez A; Bárcena P; Sanchez ML; Gutiérrez NC; San Miguel JF; Orfao A
Haematologica; 2013 Feb; 98(2):279-87. PubMed ID: 22929983
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics and molecular cytogenetics in multiple myeloma.
Liebisch P; Döhner H
Eur J Cancer; 2006 Jul; 42(11):1520-9. PubMed ID: 16781866
[TBL] [Abstract][Full Text] [Related]
7. [Fluorescence immunophenotyping and interphase cytogenetics as a tool for the investigation of cytogenetic aberrations of multiple myeloma].
Wang XW; Li JY; Chen LJ; Qian SX; Hong M; Qiao C; Zhang JF; Xu W; Lu H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1316-9. PubMed ID: 19099635
[TBL] [Abstract][Full Text] [Related]
8. [Molecular cytogenetic analyses of patients with plasma cell myeloma in Tolna and Baranya counties in Hungary].
Kosztolányi S; Horváth B; Hosnyánszki D; Kereskai L; Sziládi E; Jáksó P; Alizadeh H; Szuhai K; Alpár D; Kajtár B
Orv Hetil; 2019 Jun; 160(24):944-951. PubMed ID: 31433233
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies.
Caltagirone S; Ruggeri M; Aschero S; Gilestro M; Oddolo D; Gay F; Bringhen S; Musolino C; Baldini L; Musto P; Petrucci MT; Gaidano G; Passera R; Bruno B; Palumbo A; Boccadoro M; Omedè P
Haematologica; 2014 Oct; 99(10):1611-7. PubMed ID: 25015938
[TBL] [Abstract][Full Text] [Related]
10. Genomic Aberrations in Multiple Myeloma.
Manier S; Salem K; Glavey SV; Roccaro AM; Ghobrial IM
Cancer Treat Res; 2016; 169():23-34. PubMed ID: 27696256
[TBL] [Abstract][Full Text] [Related]
11. Molecular Cytogenetic Analysis of Chromosome 8 Aberrations in Patients With Multiple Myeloma Examined in 2 Different Stages, at Diagnosis and at Progression/Relapse.
Mlynarcikova M; Balcarkova J; Mickova P; Scudla V; Pika T; Bacovsky J; Minarik J; Janousova E; Jarosova M
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):358-65. PubMed ID: 27052024
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma.
Sawyer JR
Cancer Genet; 2011 Jan; 204(1):3-12. PubMed ID: 21356186
[TBL] [Abstract][Full Text] [Related]
13. Dissecting karyotypic patterns in non-hyperdiploid multiple myeloma: an overview on the karyotypic evolution.
Jimenez-Zepeda VH; Braggio E; Fonseca R
Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):552-8. PubMed ID: 23856591
[TBL] [Abstract][Full Text] [Related]
14. Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases.
Smadja NV; Leroux D; Soulier J; Dumont S; Arnould C; Taviaux S; Taillemite JL; Bastard C
Genes Chromosomes Cancer; 2003 Nov; 38(3):234-9. PubMed ID: 14506697
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in cytogenetic characterization of multiple myeloma.
Saxe D; Seo EJ; Bergeron MB; Han JY
Int J Lab Hematol; 2019 Feb; 41(1):5-14. PubMed ID: 29971938
[TBL] [Abstract][Full Text] [Related]
16. Analysis of genetic abnormalities provides insights into genetic evolution of hyperdiploid myeloma.
Chng WJ; Ketterling RP; Fonseca R
Genes Chromosomes Cancer; 2006 Dec; 45(12):1111-20. PubMed ID: 16955468
[TBL] [Abstract][Full Text] [Related]
17. Genetics and cytogenetics of multiple myeloma: a workshop report.
Fonseca R; Barlogie B; Bataille R; Bastard C; Bergsagel PL; Chesi M; Davies FE; Drach J; Greipp PR; Kirsch IR; Kuehl WM; Hernandez JM; Minvielle S; Pilarski LM; Shaughnessy JD; Stewart AK; Avet-Loiseau H
Cancer Res; 2004 Feb; 64(4):1546-58. PubMed ID: 14989251
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic and FISH analysis of 93 multiple myeloma Moroccan patients.
Hamdaoui H; Benlarroubia O; Ait Boujmia OK; Mossafa H; Ouldim K; Belkhayat A; Smyej I; Benrahma H; Dehbi H; Chegdani F
Mol Genet Genomic Med; 2020 Sep; 8(9):e1363. PubMed ID: 32573970
[TBL] [Abstract][Full Text] [Related]
19. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.
Fonseca R; Bergsagel PL; Drach J; Shaughnessy J; Gutierrez N; Stewart AK; Morgan G; Van Ness B; Chesi M; Minvielle S; Neri A; Barlogie B; Kuehl WM; Liebisch P; Davies F; Chen-Kiang S; Durie BG; Carrasco R; Sezer O; Reiman T; Pilarski L; Avet-Loiseau H;
Leukemia; 2009 Dec; 23(12):2210-21. PubMed ID: 19798094
[TBL] [Abstract][Full Text] [Related]
20. Genomic profiling of myeloma: the best approach, a comparison of cytogenetics, FISH and array-CGH of 112 myeloma cases.
Rack K; Vidrequin S; Dargent JL
J Clin Pathol; 2016 Jan; 69(1):82-6. PubMed ID: 26338801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
